Mendelian Randomization: Principles and its usage in Lp(a) research
Open Access
- 20 May 2022
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 349, 36-41
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular DiseaseJAMA Cardiology, 2021
- Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease OutcomesJAMA Cardiology, 2019
- Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering TherapiesJAMA Cardiology, 2018
- Semiparametric methods for estimation of a nonlinear exposure‐outcome relationship using instrumental variables with application to Mendelian randomizationGenetic Epidemiology, 2017
- Human Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesCardiovascular Drugs and Therapy, 2016
- Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methodsStatistics in Medicine, 2015
- Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factorsEuropean Journal of Epidemiology, 2015
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009